Parental Perceptions of Obesity and Obesity Risk Associated With Childhood Acute Lymphoblastic Leukemia

Gary L Jones1, Wendy McClellan, Sripriya Raman

  • 1Children's Mercy Hospital, Kansas City, MO.

Insights

Parents of childhood acute lymphoblastic leukemia (ALL) survivors often underestimate their child's obesity risk. Increased awareness and education are crucial for preventing obesity and related health issues in these young patients.

Area of Science:

  • Pediatric Oncology
  • Public Health
  • Endocrinology

Background:

  • Survivors of childhood acute lymphoblastic leukemia (ALL) face a high prevalence of obesity (29%-69%) and associated comorbidities.
  • Parental awareness of obesity risks in pediatric ALL survivors is not well understood.

Purpose of the Study:

  • To explore parental awareness of increased obesity risk in childhood acute lymphoblastic leukemia (ALL) survivors.
  • To assess parental perceptions of their child's overall health and weight status post-treatment.

Main Methods:

  • A survey was completed by 121 parents of 99 pediatric ALL survivors.
  • The survey assessed parental perceptions of obesity risk and child's weight status.

Main Results:

  • Eighty percent of parents accurately identified overweight or obese survivors as "a little overweight" or "overweight."
  • Few parents recalled discussing weight gain (21%) or obesity risk (36%) with healthcare providers.
  • Parents who discussed weight or noted decreased activity were more concerned about weight status.

Conclusions:

  • Enhanced parental awareness and education on obesity risks and comorbidities are vital for prevention in pediatric ALL survivors.
  • Routine patient visits should incorporate discussions about healthy lifestyles, including diet and exercise, for survivors.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
874
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.6K